| No images? Click here ![]() Tuesday, 24 February 2026 MEDIA ADVISORY WHO information meeting and virtual press conference: influenza vaccine composition for the 2026-2027 northern hemisphere season The World Health Organization (WHO) will hold an information meeting and a press conference following the WHO consultation on the composition of influenza virus vaccines for use in the 2026–2027 northern hemisphere influenza season. A news release will also be shared ahead of the press conference. When: Friday, 27 February 2026
Speakers at the press conference:
About the briefings During these briefings, WHO will announce the updated recommended composition of seasonal influenza vaccines for the upcoming season. Panellists, including experts from the WHO Collaborating Centres, will present the scientific evidence, and provide an update on the most recent influenza season, including the new ‘subclade K’ variant, and projections for the upcoming influenza season. WHO will also announce updates to candidate vaccine viruses (CVVs) for zoonotic influenza (‘bird’ and ‘swine flu’). These CVVs support global pandemic preparedness efforts by enabling the timely development of vaccines, should a new influenza pandemic arise. Influenza viruses constantly evolve, making it necessary to update vaccine composition periodically. Twice a year, WHO issues updated recommendations of vaccine composition, following consultations with an advisory group of experts from the WHO Global Influenza Surveillance and Response System (GISRS) using data generated by GISRS and partners. Note to journalists Please ensure you enter your name and media outlet (use name/outlet). Kindly note, only questions from media are allowed. When you sign in you will be automatically put in the meeting room. WHO reserves the right to remove any participant whose behaviour causes any disruption. To ask a question, please click "raise hand" and this will enter you into the queue for questions (it can be found under the tab: participants) or use the chat function on Zoom clearly indicating your media outlet. Please make sure you have a microphone connected or active on your computer. Do not ask questions via the chat as we cannot guarantee that we can incorporate them into the Q&A session. Media contact: mediainquiries@who.int You are receiving this NO-REPLY email because you are included on a WHO mail list. |
Tuesday, February 24, 2026
MEDIA ADVISORY: Virtual press conference on influenza vaccine composition for the 2026-2027 northern hemisphere season - Friday, 27 February at 12.00 CET
Subscribe to:
Post Comments (Atom)

No comments:
Post a Comment